219 related articles for article (PubMed ID: 21602274)
1. Activation of AMP-activated protein kinase is essential for lysophosphatidic acid-induced cell migration in ovarian cancer cells.
Kim EK; Park JM; Lim S; Choi JW; Kim HS; Seok H; Seo JK; Oh K; Lee DS; Kim KT; Ryu SH; Suh PG
J Biol Chem; 2011 Jul; 286(27):24036-45. PubMed ID: 21602274
[TBL] [Abstract][Full Text] [Related]
2. LPA-induced migration of ovarian cancer cells requires activation of ERM proteins via LPA
Park J; Jang JH; Oh S; Kim M; Shin C; Jeong M; Heo K; Park JB; Kim SR; Oh YS
Cell Signal; 2018 Apr; 44():138-147. PubMed ID: 29329782
[TBL] [Abstract][Full Text] [Related]
3. LPA receptor 1 mediates LPA-induced ovarian cancer metastasis: an in vitro and in vivo study.
Yu X; Zhang Y; Chen H
BMC Cancer; 2016 Nov; 16(1):846. PubMed ID: 27809800
[TBL] [Abstract][Full Text] [Related]
4. The G12/13-RhoA signaling pathway contributes to efficient lysophosphatidic acid-stimulated cell migration.
Bian D; Mahanivong C; Yu J; Frisch SM; Pan ZK; Ye RD; Huang S
Oncogene; 2006 Apr; 25(15):2234-44. PubMed ID: 16301993
[TBL] [Abstract][Full Text] [Related]
5. Ovarian cancer-derived lysophosphatidic acid stimulates secretion of VEGF and stromal cell-derived factor-1 alpha from human mesenchymal stem cells.
Jeon ES; Heo SC; Lee IH; Choi YJ; Park JH; Choi KU; Park DY; Suh DS; Yoon MS; Kim JH
Exp Mol Med; 2010 Apr; 42(4):280-93. PubMed ID: 20177148
[TBL] [Abstract][Full Text] [Related]
6. LPA3 is a precise therapeutic target and potential biomarker for ovarian cancer.
Zhao P; Yun Q; Li A; Li R; Yan Y; Wang Y; Sun H; Damirin A
Med Oncol; 2022 Jan; 39(2):17. PubMed ID: 34982278
[TBL] [Abstract][Full Text] [Related]
7. LPA(1) -induced migration requires nonmuscle myosin II light chain phosphorylation in breast cancer cells.
Kim JH; Adelstein RS
J Cell Physiol; 2011 Nov; 226(11):2881-93. PubMed ID: 21302283
[TBL] [Abstract][Full Text] [Related]
8. Lysophosphatidic acid receptor 2 and Gi/Src pathway mediate cell motility through cyclooxygenase 2 expression in CAOV-3 ovarian cancer cells.
Jeong KJ; Park SY; Seo JH; Lee KB; Choi WS; Han JW; Kang JK; Park CG; Kim YK; Lee HY
Exp Mol Med; 2008 Dec; 40(6):607-16. PubMed ID: 19116446
[TBL] [Abstract][Full Text] [Related]
9. Autotaxin-LPA axis regulates hMSC migration by adherent junction disruption and cytoskeletal rearrangement via LPAR1/3-dependent PKC/GSK3β/β-catenin and PKC/Rho GTPase pathways.
Ryu JM; Han HJ
Stem Cells; 2015 Mar; 33(3):819-32. PubMed ID: 25376707
[TBL] [Abstract][Full Text] [Related]
10. Integrity of SOS1/EPS8/ABI1 tri-complex determines ovarian cancer metastasis.
Chen H; Wu X; Pan ZK; Huang S
Cancer Res; 2010 Dec; 70(23):9979-90. PubMed ID: 21118970
[TBL] [Abstract][Full Text] [Related]
11. The MLK-related kinase (MRK) is a novel RhoC effector that mediates lysophosphatidic acid (LPA)-stimulated tumor cell invasion.
Korkina O; Dong Z; Marullo A; Warshaw G; Symons M; Ruggieri R
J Biol Chem; 2013 Feb; 288(8):5364-73. PubMed ID: 23319595
[TBL] [Abstract][Full Text] [Related]
12. MAGI-3 competes with NHERF-2 to negatively regulate LPA2 receptor signaling in colon cancer cells.
Lee SJ; Ritter SL; Zhang H; Shim H; Hall RA; Yun CC
Gastroenterology; 2011 Mar; 140(3):924-34. PubMed ID: 21134377
[TBL] [Abstract][Full Text] [Related]
13. Lysophosphatidic acid induces prostate cancer PC3 cell migration via activation of LPA(1), p42 and p38alpha.
Hao F; Tan M; Xu X; Han J; Miller DD; Tigyi G; Cui MZ
Biochim Biophys Acta; 2007 Jul; 1771(7):883-92. PubMed ID: 17531530
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms in LPA-induced tumor cell migration: critical role of phosphorylated ERK.
Stähle M; Veit C; Bachfischer U; Schierling K; Skripczynski B; Hall A; Gierschik P; Giehl K
J Cell Sci; 2003 Sep; 116(Pt 18):3835-46. PubMed ID: 12902401
[TBL] [Abstract][Full Text] [Related]
15. [Lysophosphatidic acid (LPA) stimulates invasion and metastatic colonization of ovarian cancer cells through Rac activation].
Yu X; Zhang Y; Chen H
Zhonghua Zhong Liu Za Zhi; 2015 Feb; 37(2):95-100. PubMed ID: 25975684
[TBL] [Abstract][Full Text] [Related]
16. Matricellular protein Cyr61 bridges lysophosphatidic acid and integrin pathways leading to cell migration.
Wu DD; Zhang F; Hao F; Chun J; Xu X; Cui MZ
J Biol Chem; 2014 Feb; 289(9):5774-83. PubMed ID: 24371135
[TBL] [Abstract][Full Text] [Related]
17. Lysophosphatidic acid induction of urokinase plasminogen activator secretion requires activation of the p38MAPK pathway.
Estrella VC; Eder AM; Liu S; Pustilnik TB; Tabassam FH; Claret FX; Gallick GE; Mills GB; Wiener JR
Int J Oncol; 2007 Aug; 31(2):441-9. PubMed ID: 17611702
[TBL] [Abstract][Full Text] [Related]
18. Lysophosphatidic acid induces focal adhesion assembly through Rho/Rho-associated kinase pathway in human ovarian cancer cells.
Sawada K; Morishige Ki; Tahara M; Ikebuchi Y; Kawagishi R; Tasaka K; Murata Y
Gynecol Oncol; 2002 Dec; 87(3):252-9. PubMed ID: 12468322
[TBL] [Abstract][Full Text] [Related]
19. Lysophosphatidic acid receptor activation affects the C13NJ microglia cell line proteome leading to alterations in glycolysis, motility, and cytoskeletal architecture.
Bernhart E; Kollroser M; Rechberger G; Reicher H; Heinemann A; Schratl P; Hallström S; Wintersperger A; Nusshold C; DeVaney T; Zorn-Pauly K; Malli R; Graier W; Malle E; Sattler W
Proteomics; 2010 Jan; 10(1):141-58. PubMed ID: 19899077
[TBL] [Abstract][Full Text] [Related]
20. Activated CAMKKβ-AMPK signaling promotes autophagy in a spheroid model of ovarian tumour metastasis.
Laski J; Singha B; Wang X; Valdés YR; Collins O; Shepherd TG
J Ovarian Res; 2020 May; 13(1):58. PubMed ID: 32393385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
